These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 22334969

  • 1. Bone mineral density trends in Indian patients with hyperthyroidism--effect of antithyroid therapy.
    Dhanwal DK, Gupta N.
    J Assoc Physicians India; 2011 Sep; 59():561-2, 567. PubMed ID: 22334969
    [Abstract] [Full Text] [Related]

  • 2. Reduced bone mineral density at diagnosis and bone mineral recovery during treatment in children with Graves' disease.
    Lucidarme N, Ruiz JC, Czernichow P, Léger J.
    J Pediatr; 2000 Jul; 137(1):56-62. PubMed ID: 10891822
    [Abstract] [Full Text] [Related]

  • 3. Bone loss in hyperthyroid patients and in former hyperthyroid patients controlled on medical therapy: influence of aetiology and menopause.
    Jódar E, Muñoz-Torres M, Escobar-Jiménez F, Quesada-Charneco M, Lund del Castillo JD.
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):279-85. PubMed ID: 9373448
    [Abstract] [Full Text] [Related]

  • 4. [Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
    Lupoli GA, Fittipaldi MR, Fonderico F, Panico A, Colarusso S, Di Micco L, Cavallo A, Costa L, Paglione A, Lupoli G.
    Minerva Endocrinol; 2005 Jun; 30(2):89-94. PubMed ID: 15988404
    [Abstract] [Full Text] [Related]

  • 5. [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism].
    Yang LJ, Shen FX, Zheng JC, Zhang HL.
    Zhongguo Gu Shang; 2012 Feb; 25(2):133-7. PubMed ID: 22577718
    [Abstract] [Full Text] [Related]

  • 6. Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial.
    Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD.
    J Bone Miner Res; 2000 May; 15(5):944-51. PubMed ID: 10804025
    [Abstract] [Full Text] [Related]

  • 7. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, Jorgesen B, McGregor C, Schulman L.
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [Abstract] [Full Text] [Related]

  • 8. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H, Papapetrou PD.
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [Abstract] [Full Text] [Related]

  • 9. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.
    Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.
    J Am Geriatr Soc; 2007 May; 55(5):752-7. PubMed ID: 17493196
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK, Chadha M, Modi KD, Kumar KM, Mehrotra R, Sriram U.
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [Abstract] [Full Text] [Related]

  • 11. Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism.
    Jódar E, Muñoz-Torres M, Escobar-Jiménez F, Quesada M, Luna JD, Olea N.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1989-94. PubMed ID: 9177418
    [Abstract] [Full Text] [Related]

  • 12. [Changes of bone and mineral metabolism in patients with hyperthyroidism before and after treatment].
    Chai R, Ye Z, Zhan Z.
    Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):682-4. PubMed ID: 11038794
    [Abstract] [Full Text] [Related]

  • 13. Rapid restoration of bone mass after surgical management of hyperthyroidism: A prospective case control study in Southern India.
    Karunakaran P, Maharajan C, Mohamed KN, Rachamadugu SV.
    Surgery; 2016 Mar; 159(3):771-6. PubMed ID: 26582500
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of bone mineral density in hyperthyroid patients before and after medical therapy].
    Safi S, Hassikou H, Hadri L, Sbihi A, Kadiri A.
    Ann Endocrinol (Paris); 2006 Mar; 67(1):27-31. PubMed ID: 16596054
    [Abstract] [Full Text] [Related]

  • 15. [Parathyroid function in hyperthyroidism: implications for bone metabolism and effect of the treatment].
    Furlanetto RP, Castro ML, de Mesquita CH, Kasamatsu TS, Vieira JG.
    Rev Paul Med; 1991 Mar; 109(2):55-60. PubMed ID: 1909454
    [Abstract] [Full Text] [Related]

  • 16. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study.
    Osman F, Franklyn JA, Holder RL, Sheppard MC, Gammage MD.
    J Am Coll Cardiol; 2007 Jan 02; 49(1):71-81. PubMed ID: 17207725
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of osteoporosis among postmenopausal females with diabetes mellitus.
    Al-Maatouq MA, El-Desouki MI, Othman SA, Mattar EH, Babay ZA, Addar M.
    Saudi Med J; 2004 Oct 02; 25(10):1423-7. PubMed ID: 15494815
    [Abstract] [Full Text] [Related]

  • 18. Bone mineral density in hyperthyroidism.
    Karga H, Papapetrou PD, Korakovouni A, Papandroulaki F, Polymeris A, Pampouras G.
    Clin Endocrinol (Oxf); 2004 Oct 02; 61(4):466-72. PubMed ID: 15473879
    [Abstract] [Full Text] [Related]

  • 19. Hypovitaminosis D and bone mineral metabolism and bone density in hyperthyroidism.
    Dhanwal DK, Kochupillai N, Gupta N, Cooper C, Dennison EM.
    J Clin Densitom; 2010 Oct 02; 13(4):462-6. PubMed ID: 20663698
    [Abstract] [Full Text] [Related]

  • 20. Bone changes in hyperthyroidism--a preliminary study.
    Chen ST, Huang MJ, Juang JH, Lin JD, Huang BY, Huang HS, Tzen KY.
    Changgeng Yi Xue Za Zhi; 1990 Dec 02; 13(4):274-81. PubMed ID: 2282564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.